BioRem Price To Sales Ratio vs Ptb Ratio Analysis
BRM Stock | CAD 1.94 0.06 3.19% |
BioRem financial indicator trend analysis is way more than just evaluating BioRem Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioRem Inc is a good investment. Please check the relationship between BioRem Price To Sales Ratio and its Ptb Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Price To Sales Ratio vs Ptb Ratio
Price To Sales Ratio vs Ptb Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioRem Inc Price To Sales Ratio account and Ptb Ratio. At this time, the significance of the direction appears to have no relationship.
The correlation between BioRem's Price To Sales Ratio and Ptb Ratio is 0.09. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ptb Ratio in the same time period over historical financial statements of BioRem Inc, assuming nothing else is changed. The correlation between historical values of BioRem's Price To Sales Ratio and Ptb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of BioRem Inc are associated (or correlated) with its Ptb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ptb Ratio has no effect on the direction of Price To Sales Ratio i.e., BioRem's Price To Sales Ratio and Ptb Ratio go up and down completely randomly.
Correlation Coefficient | 0.09 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing BioRem Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BioRem sales, a figure that is much harder to manipulate than other BioRem Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most indicators from BioRem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioRem Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. At this time, BioRem's Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 72.5 K in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.06 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 24.5M | 28.9M | 25.2M | 18.5M | Depreciation And Amortization | 343.6K | 350.6K | 382.7K | 281.4K |
BioRem fundamental ratios Correlations
Click cells to compare fundamentals
BioRem Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BioRem fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 17.6M | 22.0M | 19.2M | 20.7M | 24.1M | 15.1M | |
Other Current Liab | 1.9M | 3.3M | 3.4M | 4.2M | 2.7M | 2.0M | |
Total Current Liabilities | 5.9M | 7.8M | 13.2M | 12.9M | 13.9M | 7.9M | |
Total Stockholder Equity | 11.7M | 13.5M | 2.0M | 4.5M | 6.7M | 6.0M | |
Property Plant And Equipment Net | 372.9K | 1.4M | 1.1M | 1.0M | 2.0M | 2.1M | |
Net Debt | (6.4M) | (8.0M) | 1.2M | 971.1K | 1.9M | 2.0M | |
Retained Earnings | (9.1M) | (7.0M) | (5.7M) | (4.1M) | (1.9M) | (2.0M) | |
Cash | 6.5M | 8.9M | 4.5M | 3.8M | 2.3M | 3.1M | |
Non Current Assets Total | 3.1M | 3.7M | 3.0M | 3.0M | 3.5M | 1.9M | |
Cash And Short Term Investments | 6.5M | 8.9M | 4.5M | 3.8M | 2.3M | 2.7M | |
Net Receivables | 5.7M | 7.6M | 10.1M | 12.2M | 15.1M | 7.8M | |
Common Stock Shares Outstanding | 38.7M | 39.5M | 37.4M | 17.6M | 17.1M | 22.9M | |
Liabilities And Stockholders Equity | 17.6M | 22.0M | 19.2M | 20.7M | 24.1M | 15.1M | |
Inventory | 1.3M | 944.8K | 901.7K | 888.0K | 901.1K | 764.8K | |
Other Current Assets | 1.0M | 857.3K | 658.9K | 870.6K | 2.3M | 2.4M | |
Other Stockholder Equity | 2.2M | 2.2M | 2.2M | 2.3M | 2.4M | 2.3M | |
Total Liab | 5.9M | 8.4M | 17.2M | 16.2M | 17.4M | 9.0M | |
Total Current Assets | 14.5M | 18.3M | 16.2M | 17.8M | 20.6M | 12.4M | |
Accounts Payable | 2.4M | 1.8M | 5.1M | 4.7M | 6.1M | 3.4M | |
Accumulated Other Comprehensive Income | 1.4M | 1.1M | 597.3K | 1.4M | 1.3M | 653.8K | |
Current Deferred Revenue | 1.6M | 2.5M | 3.0M | 2.6M | 4.3M | 4.5M | |
Net Tangible Assets | 12.9M | 11.7M | 13.5M | 2.0M | 2.3M | 2.1M | |
Property Plant Equipment | 262.5K | 372.9K | 1.4M | 1.1M | 1.3M | 1.4M | |
Net Invested Capital | 11.7M | 13.5M | 7.0M | 8.8M | 9.7M | 8.1M | |
Net Working Capital | 8.6M | 10.5M | 2.9M | 4.9M | 6.7M | 5.8M |
Pair Trading with BioRem
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioRem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRem will appreciate offsetting losses from the drop in the long position's value.Moving together with BioRem Stock
0.69 | GOOG | Alphabet CDR | PairCorr |
Moving against BioRem Stock
0.73 | IBM | International Business | PairCorr |
0.72 | PFE | Pfizer Inc CDR | PairCorr |
0.44 | MSFT | Microsoft Corp CDR | PairCorr |
The ability to find closely correlated positions to BioRem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioRem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioRem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioRem Inc to buy it.
The correlation of BioRem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioRem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioRem Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioRem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for BioRem Stock analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |